Category: Biotechnology Company Reports
Biotechnology Company Reports market research reports by Plunkett Research, Ltd.
-
Aziyo Biologics Inc (AZYO:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Aziyo Biologics Inc (AZYO:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Aziyo Biologics Inc (AZYO:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. T ... Read More
-
Caribou Biosciences Inc (CRBU:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Caribou Biosciences Inc (CRBU:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Caribou Biosciences Inc (CRBU:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Fin ... Read More
-
Puma Biotechnology Inc (PBYI:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Puma Biotechnology Inc (PBYI:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Puma Biotechnology Inc (PBYI:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findi ... Read More
-
Agilent Technologies Inc (A:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Agilent Technologies Inc (A:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Agilent Technologies Inc (A:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Finding ... Read More
-
4D Molecular Therapeutics Inc (FDMT:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
4D Molecular Therapeutics Inc (FDMT:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry 4D Molecular Therapeutics Inc (FDMT:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Indus ... Read More
-
Histogen Inc (HSTO:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Histogen Inc (HSTO:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Histogen Inc (HSTO:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new ... Read More
-
Anika Therapeutics Inc (ANIK:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Anika Therapeutics Inc (ANIK:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Anika Therapeutics Inc (ANIK:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findi ... Read More
-
Aceragen Inc (ACGN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Aceragen Inc (ACGN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Aceragen Inc (ACGN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new ... Read More
-
Myriad Genetics Inc (MYGN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Myriad Genetics Inc (MYGN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Myriad Genetics Inc (MYGN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. T ... Read More
-
Geron Corporation (GERN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Geron Corporation (GERN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Geron Corporation (GERN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This ... Read More
-
Matinas BioPharma Hldgs Inc (MTNB:ASE): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Matinas BioPharma Hldgs Inc (MTNB:ASE): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Matinas BioPharma Hldgs Inc (MTNB:ASE): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. ... Read More
-
Albireo Pharma Inc (ALBO:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Albireo Pharma Inc (ALBO:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Albireo Pharma Inc (ALBO:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. Thi ... Read More
-
Natera Inc (NTRA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Natera Inc (NTRA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Natera Inc (NTRA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new rep ... Read More
-
Fate Therapeutics Inc (FATE:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Fate Therapeutics Inc (FATE:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Fate Therapeutics Inc (FATE:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Finding ... Read More
-
Nektar Therapeutics (NKTR:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Nektar Therapeutics (NKTR:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Nektar Therapeutics (NKTR:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. T ... Read More
-
Amgen Inc (AMGN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Amgen Inc (AMGN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Amgen Inc (AMGN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new repor ... Read More
-
Regen BioPharma Inc (RGBP:PINX): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Regen BioPharma Inc (RGBP:PINX): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Regen BioPharma Inc (RGBP:PINX): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. ... Read More
-
ADMA Biologics Inc (ADMA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
ADMA Biologics Inc (ADMA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry ADMA Biologics Inc (ADMA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. Thi ... Read More
-
United Therapeutics Corporation (UTHR:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
United Therapeutics Corporation (UTHR:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry United Therapeutics Corporation (UTHR:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its I ... Read More
-
Cerus Corporation (CERS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Cerus Corporation (CERS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Cerus Corporation (CERS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This ... Read More
-
Gilead Sciences Inc (GILD:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Gilead Sciences Inc (GILD:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Gilead Sciences Inc (GILD:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. T ... Read More
-
US Stem Cell Inc (USRM:PINX): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
US Stem Cell Inc (USRM:PINX): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry US Stem Cell Inc (USRM:PINX): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This ... Read More
-
Foghorn Therapeutics Inc (FHTX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Foghorn Therapeutics Inc (FHTX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for Foghorn Therapeutics Inc (FHTX:NAS) compared to its top competitors and compared t ... Read More
-
Eiger BioPharmaceuticals (EIGR:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Eiger BioPharmaceuticals (EIGR:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for Eiger BioPharmaceuticals (EIGR:NAS) compared to its top competitors and compared t ... Read More
-
Karuna Therapeutics Inc (KRTX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Karuna Therapeutics Inc (KRTX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for Karuna Therapeutics Inc (KRTX:NAS) compared to its top competitors and compared to ... Read More
Research Assistance
